Skip to Content Skip to Navigation

About us Practical matters How to find us J. Luttjeboer, MSc

University Medical Center Groningen

J. Luttjeboer, MSc

No picture available

Faculty of Medical Sciences

Telephone:

E-mail:

j.luttjeboer umcg.nl

Research Portal

Publications

An Updated Analysis of the Impact of HPV Vaccination Based on Long-term Effectiveness in the Netherlands

Luttjeboer, J., Simons, J., Westra, T., Wilschut, J., Boersma, C., Postma, M. & van der Schans, J., Aug-2023, In: Infectious diseases and therapy. 12, 8, p. 2135-2145 11 p.

Research output: Contribution to journal › Article › Academic › peer-review

Exploratory Analysis of the Economically Justifiable Price of a Hypothetical RSV Vaccine for Older Adults in the Netherlands and the United Kingdom

RESCEU Investigators, Zeevat, F., Luttjeboer, J., Paulissen, J. H. J., van der Schans, J., Beutels, P., Boersma, C. & Postma, M. J., 12-Aug-2022, In: The Journal of Infectious Diseases. 226, 1, p. S102-S109 8 p.

Research output: Contribution to journal › Article › Academic › peer-review

'It takes two to tango': Bridging the gap between country need and vaccine product innovation

Archer, R. A., Kapoor, R., Isaranuwatchai, W., Teerawattananon, Y., Giersing, B., Botwright, S., Luttjeboer, J. & Hutubessy, R. C. W., 10-Jun-2020, In: PLoS ONE. 15, 6, 11 p., 0233950.

Research output: Contribution to journal › Article › Academic › peer-review

Maximising the potential of HPV vaccines

Luttjeboer, J., Wondimu, A., Van der Schans, J. & Postma, M. J., Apr-2020, In: The Lancet Global Health. 8, 4, p. E460-E461 2 p.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

A Cost Minimization Analysis of Ready-to-Administer Prefilled Sterilized Syringes in a Dutch Hospital

Larmene-Beld, K. H. M., Touwen-Spronk, J., Luttjeboer, J., Taxis, K. & Postma, M. J., Jun-2019, In: Clinical Therapeutics. 41, 6, p. 1139-1150 12 p.

Research output: Contribution to journal › Article › Academic › peer-review

EXPLORATORY ANALYSIS OF THE ECONOMICALLY JUSTIFIABLE PRICE OF AN RSV VACCINE FOR THE ELDERLY IN THE NETHERLANDS AND THE UNITED KINGDOM

Zeevat, F., Luttjeboer, J., Beutels, P., Boersma, C. & Postma, M., Nov-2019, In: Value in Health. 22, S3, p. S643-S644 2 p., PIN25.

Research output: Contribution to journal › Meeting Abstract › Academic

Immunogenicity and safety of human papillomavirus (HPV) vaccination in Asian populations from six countries: a meta-analysis

Setiawan, D., Luttjeboer, J., Pouwels, K. B., Wilschut, J. C. & Postma, M. J., Mar-2017, In: Japanese journal of clinical oncology. 47, 3, p. 265-276 12 p.

Research output: Contribution to journal › Article › Academic › peer-review

A Model Based Cost-Effectiveness Analysis of Routine Genotyping for CYP2D6 among Older, Depressed Inpatients Starting Nortriptyline Pharmacotherapy

Berm, E. J. J., Gout-Zwart, J. J., Luttjeboer, J., Wilffert, B. & Postma, M. J., 29-Dec-2016, In: PLoS ONE. 11, 12, 16 p., e0169065.

Research output: Contribution to journal › Article › Academic › peer-review

Threshold cost-effectiveness analysis for a therapeutic vaccine against HPV-16/18-positive cervical intraepithelial neoplasia in the Netherlands

Luttjeboer, J., Setiawan, D., Cao, Q., Daemen, T. C. & Postma, M. J., 7-Dec-2016, In: Vaccine. 34, 50, p. 6381-6387 7 p.

Research output: Contribution to journal › Article › Academic › peer-review

Cost-effectiveness of Cyp2d6 genotyping in older depressed patients, starting with nortriptyline therapy

Berm, E. J., Gout-Zwart, J. J., Luttjeboer, J., Maring, J. G., Wilffert, B. & Postma, M. J., 1-May-2015, In: Value in Health. 18, 3, p. 107 1 p.

Research output: Contribution to journal › Meeting Abstract › Academic

All (14) publications

View full research profile

Follow the UGfacebook twitter linkedin rss instagram youtube